To Be Discontinued Tablet Antiviral
Elbasvir; Grazoprevir Tablet · 329 days since initial FDA posting
Brand: ZEPATIER
FDA lists Elbasvir; Grazoprevir Tablet as To Be Discontinued (Merck Sharp & Dohme LLC).
No availability text on this FDA row.
Elbasvir; Grazoprevir Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Elbasvir; Grazoprevir Tablet
- Manufacturer
- Merck Sharp & Dohme LLC
- Dosage Form
- Tablet
- Presentation
- Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02)
- Package NDC
- 0006-3074-02
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Oct 17, 2025
- Last Updated
- Oct 17, 2025
- Therapeutic Category
- Antiviral
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
To be discontinued December 1, 2025
FDA reason on file: To be discontinued December 1, 2025. General shortage guidance lives on the tracker hub.